Abstract
The present paper focuses on drug-evaluation research, and describes a method of meta-analysis for evaluating the methodological quality of a body of research focusing on the study of an acute treatment medication. An illustrative application of this procedure to research evaluating lithium treatment for acute mania revealed general problems with diagnostic reliability and the reliability of the dependent variable, and a tendency to ignore the statistical power aspects of determining sample size. The implications of this are discussed in terms of a need to further clarify lithium's role in treating this disorder.
